Physician

Albert Attah-Kofi Sey, M.D

According to 2025 Medicare claims, Albert Sey, M.D (NPI: 1396051785) practices cardiology in the Columbus, IN market, with the plurality of this provider's patient population coming from Bartholomew, IN. This provider's primary affiliated billing organization is COLUMBUS REGIONAL HEALTH PHYSICIANS, LLC (NPI: 1336510098; TIN: 474898741) and primary practice location at 47201-5351. Sey is affiliated with the Franciscan ACO, Inc. (ACO ID: A2550), Inspire Health Partners, LLC (ACO ID: A3555), CHSPSC ACO 2, LLC (ACO ID: A3664), Caravan Collaborative Pathways (ACO ID: A4604), and WellStar Clinical Partners Medicare ACO, LLC (ACO ID: A4803), participating under the MSSP model.

Sey's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 435 traditional Medicare patients, billed 1,164 HCPCS/CPT codes, and received $151,790 in Medicare payments. The top billing code was 93656 (Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation). Part D data shows 1,403 prescription claims across 262 beneficiaries totaling $404,499 in drug costs, led by Eliquis (Apixaban). 2015 DME data shows 22 claims. Open Payments data shows 45 records totaling $2,731. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $64,069 to $151,790. Similarly, Part D prescription costs have risen steadily, from $5,735 to $404,499. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	325	622	$64,069
2016	28	31	$2,685
2017	51	71	$5,309
2018	73	102	$9,256
2019	N/R	N/R	N/R
2020	141	267	$17,164
2021	327	1,254	$98,317
2022	307	1,108	$83,074
2023	415	960	$106,055
2024	435	1,164	$151,790

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	51	154	$5,735
2016	32	129	$8,417
2017	22	109	$4,770
2018	32	77	$9,250
2019	29	93	$25,672
2020	95	191	$43,313
2021	272	1,220	$265,907
2022	289	1,634	$460,415
2023	298	1,042	$237,963
2024	262	1,403	$404,499

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	22	$1,823
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93656	Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation	78	80	$585
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	57	57	$116
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	90	90	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	64	78	$55
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	66	93	$37

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	252	12,896	$243,603
Xarelto	Rivaroxaban	83	4,825	$87,756
Entresto	Sacubitril/Valsartan	41	2,130	$43,206
Flecainide Acetate	Flecainide Acetate	86	6,031	$3,464
Metoprolol Succinate	Metoprolol Succinate	197	14,528	$2,158

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	45	$2,731	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Albert Attah-Kofi Sey, M.D?

Tedicare shows public-source Medicare data for Albert Attah-Kofi Sey, M.D (NPI 1396051785), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Albert Attah-Kofi Sey, M.D have ACO affiliation data?

Albert Attah-Kofi Sey, M.D is shown with ACO affiliation data for Franciscan ACO, Inc. (MSSP, ACO ID A2550), Inspire Health Partners, LLC (MSSP, ACO ID A3555), CHSPSC ACO 2, LLC (MSSP, ACO ID A3664), Caravan Collaborative Pathways (MSSP, ACO ID A4604), and WellStar Clinical Partners Medicare ACO, LLC (MSSP, ACO ID A4803).

What billing organization is linked to Albert Attah-Kofi Sey, M.D?

Albert Attah-Kofi Sey, M.D is linked to COLUMBUS REGIONAL HEALTH PHYSICIANS, LLC (billing NPI 1336510098) in the available physician profile data.

Does Albert Attah-Kofi Sey, M.D have Open Payments data?

Albert Attah-Kofi Sey, M.D has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.